Estrogen-related receptor alpha (ERRα), a protein in the nucleus of breast cancer cells, plays a key part in the growth of aggressive tumors - new medications that undermine the activity of the protein might help treat some types of breast cancers known as estrogen receptor negative cancers, researchers from the Duke Cancer Institute reported in the journal Cancer Cell...
More...